Factorial study of Metoprolol Succinate TOPROL-XL (324A)

Study identifier:D4026C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A phase III, Multi-center, randomized, Double-blind, placebo-controlled, parallel-group factorial study of Metoprolol Succinate extended release tablets (TOPROL-XL) Hydrochlorothiazide and their combination in patients with essential hypertension.

Medical condition

High blood pressure (hypertension).

Phase

Phase 3

Healthy volunteers

No

Study drug

Metoprolol Succinate, Hydrochlorothiazide

Sex

All

Actual Enrollment

1900

Study type

Interventional

Age

18 Years - 80 Years

Date

Study Start Date: 01 Jun 2003
Primary Completion Date: 01 Jul 2004
Study Completion Date: 01 Jul 2004

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Mar 2009 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria